 |
|
| Type | Public (NASDAQ: ARIA) |
|---|---|
| Founded | 1991 |
| Headquarters | Cambridge, MA, United States |
| Key people | Harvey Berger, Chairman & CEO |
| Industry | Pharmaceuticals |
| Products | Ridaforolimus (Under development) |
| Revenue | ▲$3.58 million USD (2007) |
| Operating income | ▼$-60.69 million USD (2007) |
| Net income | ▼$-58.52 million USD (2007) |
| Employees | 116 (2007) |
| Website | www.ariad.com |
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) is a small pharmaceutical companies working on cancer drugs. The company is located in Cambridge, Massachusetts. It was established in 1991. It has strong partnerships with Merck.
Contents |
|
|
Wikis
Map
Search
